Top upgrades and downgrades on 6/21: XOM, ADBE, UAA, BEKE and more

Analysts Notebook wrote a column · Jun 21, 2022 06:06

Upgrades

• $ABM Industries(ABM.US)$ : Baird Upgrades to Outperform from Neutral - PT $50

• $American Tower Corp(AMT.US)$ : JPMorgan Upgrades to Overweight from Underweight - PT $285 (from $245)

• $Church & Dwight(CHD.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $95

• $Chewy(CHWY.US)$ : Wedbush Upgrades to Outperform from Neutral - PT $35 (from $30)

• $Centene(CNC.US)$ : Credit Suisse Upgrades to Outperform from Neutral - PT $88 (from $86)

• $CubeSmart(CUBE.US)$ : BofA Securities Upgrades to Buy from Neutral

• $FMC Corp(FMC.US)$ : BofA Securities Upgrades to Buy from Underperform

• $LTC Properties Inc(LTC.US)$ : BMO Capital Upgrades to Market Perform from Underperform - PT $40 (from $37)

• $Charles Schwab(SCHW.US)$ : UBS Upgrades to Buy from Neutral - PT $75 (from $68)

• $Exxon Mobil(XOM.US)$ : Credit Suisse Upgrades to Outperform from Neutral - PT $125 (from $115)

Downgrades

• $Adobe(ADBE.US)$ : Morgan Stanley Downgrades to Equalweight from Overweight - PT $362 (from $591)

• $Aveanna Healthcare(AVAH.US)$ : Stephens Downgrades to Equal Weight from Overweight - PT $3.50 (from $5.50)

• $Hyliion(HYLN.US)$ : JPMorgan Downgrades to Underweight from Neutral

• $International Paper(IP.US)$ : Citigroup Downgrades to Neutral from Buy - PT $46 (from $53)

• $Life Storage, Inc.(LSI.US)$ : BofA Securities Downgrades to Neutral from Buy

• $National Health Investors Inc(NHI.US)$ : BMO Capital Downgrades to Market Perform from Outperform - PT $62

• $Sunnova Energy International(NOVA.US)$ : Goldman Sachs Downgrades to Neutral from Buy - PT $24 (from $31)

• $Pennant Group(PNTG.US)$ : Stephens Downgrades to Equal Weight from Overweight - PT $17 (from $23)

• $SunPower(SPWR.US)$ : Goldman Sachs Downgrades o Sell from Neutral - PT $13 (from $19)

• $Under Armour-A(UAA.US)$ : Cowen Downgrades to Market Perform from Outperform - PT $10 (from $13)

• $WestRock(WRK.US)$ : Citigroup Downgrades to Neutral from Buy - PT $45 (from $53)

Initiated

• $Arvinas(ARVN.US)$ : Jefferies initiates at Hold - PT $42

• $KE Holdings(BEKE.US)$ : Citigroup initiates at Buy - PT $22.50

• $Compass(COMP.US)$ : Compass Point initiates at Buy - PT $8

• $Embecta(EMBC.US)$ : BofA Securities initiates at Underperform - PT $25

• $FREYR Battery(FREY.US)$ : Goldman Sachs initiates at Neutral - PT $8

• $Maxar Technologies(MAXR.US)$ : Wells Fargo initiates at Overweight - PT $39

• $Mainz Biomed(MYNZ.US)$ : H.C. Wainwright initiates at Buy - PT $25

• $Inari Medical(NARI.US)$ : Piper Sandler initiates at Overweight - PT $100

• $Offerpad Solutions(OPAD.US)$ : Compass Point initiates at Buy - PT $5.50

• $Opendoor Technologies(OPEN.US)$ : Compass Point initiates at Neutral - PT $6

• $Palantir(PLTR.US)$ : BofA Securities initiates at Buy - PT $13

• $Rexford Industrial Realty Inc(REXR.US)$ : Wolfe Research initiates at Peerperform - PT $63

• $Rocket Lab(RKLB.US)$ : Wells Fargo initiates at Equal Weight - PT $5

• $Virgin Galactic(SPCE.US)$ : Wells Fargo initiates at Underweight - PT $4

• $Symbotic(SYM.US)$ : Cowen initiates at Outperform - PT $18

• $Tenon Medical(TNON.US)$ : Benchmark initiates at Speculative Buy - PT $6

Moomoo Inc. ("moomoo") provides mobile and online technology solutions for securities trading. Moomoo is not an investment adviser or a broker-dealer and it provides neither investment or financial advice nor securities trading services. All contents such as comments and links posted or shared by users of the community are opinions of the respective authors only and do not reflect the opinions, views, or positions of moomoo, its affiliates, or any employees of moomoo or its affiliates. Please consult a qualified investment or tax advisor for your personal financial planning and tax situations.

Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only. Read more

Translate

Report

630K Views

Comment

Analysts Notebook

Moomoo News Official Account

How do analysts evaluate the market?

15KFollowers

8Following

35KVisitors